Sarcopenia impairs prognosis of patients with liver cirrhosis

Nutrition

Volumn 31, Issue 1, 2015, Pages 193-199

  Hanai, Tatsunori ^a   Shiraki, Makoto ^a   Nishimura, Kayoko ^b   Ohnishi, Sachiyo ^a   Imai, Kenji ^a   Suetsugu, Atsushi ^a   Takai, Koji ^a   Shimizu, Masahito ^a   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Branched chain amino acids; Liver cirrhosis; Protein energy malnutrition; Sarcopenia; Skeletal muscle index; Survival

Indexed keywords

BRANCHED CHAIN AMINO ACID;

ADULT; AGED; ANATOMY; ARTICLE; BODY MASS; CAUSE OF DEATH; CHILD PUGH SCORE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SARCOPENIA; SKELETAL MUSCLE; SURVIVAL; VERY ELDERLY; BODY WEIGHT; CROSS-SECTIONAL STUDY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS, BRANCHED-CHAIN; BODY MASS INDEX; BODY WEIGHT; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOPENIA; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84922261335     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.07.005     Document Type: Article

References (39)

1. Merli M., Riggio O., Dally L. Does malnutrition affect survival in cirrhosis?. Hepatology 1996, 23:1041-1046.
2. Peng S., Plank L.D., McCall J.L., Gillanders L.K., McIlroy K., Gane E.J. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr 2007, 85:1257-1266.
3. Alberino F., Gatta A., Amodio P., Merkel C., Di Pascoli L., Boffo G., et al. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001, 17:445-450.
4. Tajika M., Kato M., Mohri H., Miwa Y., Kato T., Ohnishi H., et al. Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition 2002, 18:229-234.
5. Moriwaki H., Shiraki M., Fukushima H., Shimizu M., Iwasa J., Naiki T., et al. Long-term outcome of branched-chain amino acid treatment in patients with liver cirrhosis. Hepatol Res 2008, 38:S102-S106.
6. Suzuki K., Endo R., Kohgo Y., Ohtake T., Ueno Y., Kato A., et al. Guidelines on nutritional management in Japanese patients with liver cirrhosis from the perspective of preventing hepatocellular carcinoma. Hepatol Res 2012, 42:621-626.
7. Plauth M., Cabre E., Riggio O., Assis-Camilo M., Pirlich M., Kondrup J., et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 2006, 25:285-294.
8. Charlton M. Branched-chain amino acid-enriched supplements as therapy for liver disease: Rasputin lives. Gastroenterology 2003, 124:1980-1982.
9. Muto Y., Sato S., Watanabe A., Moriwaki H., Suzuki K., Kato A., et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005, 3:705-713.
10. Marchesini G., Bianchi G., Merli M., Amodio P., Panella C., Loguercio C., et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 2003, 124:1792-1801. Italian BSG.
11. Nakaya Y., Okita K., Suzuki K., Moriwaki H., Kato A., Miwa Y., et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007, 23:113-120.
12. Amodio P., Bemeur C., Butterworth R., Cordoba J., Kato A., Montagnese S., et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism consensus. Hepatology 2013, 58:325-336.
13. Montano-Loza A.J., Meza-Junco J., Prado C.M., Lieffers J.R., Baracos V.E., Bain V.G., et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012, 10:166-173. 173 e161.
14. Tandon P., Ney M., Irwin I., Ma M.M., Gramlich L., Bain V.G., et al. Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value. Liver Transpl 2012, 18:1209-1216.
15. Periyalwar P., Dasarathy S. Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses. Clin Liver Dis 2012, 16:95-131.
16. Englesbe M.J., Patel S.P., He K., Lynch R.J., Schaubel D.E., Harbaugh C., et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010, 211:271-278.
17. Tsien C.D., McCullough A.J., Dasarathy S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol 2012, 27:430-441.
18. Tessari P. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils. Curr Opin Clin Nutr Metab Care 2003, 6:79-85.
19. Dasarathy S. Consilience in sarcopenia of cirrhosis. J Cachexia Sarcopenia Muscle 2012, 3:225-237.
20. Owen O.E., Trapp V.E., Reichard G.A., Mozzoli M.A., Moctezuma J., Paul P., et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 1983, 72:1821-1832.
21. Nicastro H., Artioli G.G., Costa Ados S., Solis M.Y., da Luz C.R., Blachier F., et al. An overview of the therapeutic effects of leucine supplementation on skeletal muscle under atrophic conditions. Amino Acids 2011, 40:287-300.
22. Kaido T., Ogawa K., Fujimoto Y., Ogura Y., Hata K., Ito T., et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant 2013, 13:1549-1556.
23. Katsanos C.S., Kobayashi H., Sheffield-Moore M., Aarsland A., Wolfe R.R. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab 2006, 291:E381-E387.
24. Kawaguchi T., Izumi N., Charlton M.R., Sata M. Branched-chain amino acids aspharmacologic nutrients in chronic liver disease. Hepatology 2011, 54:1063-1070.
25. Kato M., Miwa Y., Tajika M., Hiraoka T., Muto Y., Moriwaki H. Preferential use of branched-chain amino acids as an energy substrate in patients with liver cirrhosis. Intern Med 1998, 37:429-434.
26. Moriwaki H., Miwa Y., Tajika M., Kato M., Fukushima H., Shiraki M. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun 2004, 313:405-409.
27. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., Williams R. Transectionof the oesophagus for bleeding oesophageal varices. Br J Surg 1973, 60:646-649.
28. Shen W., Punyanitya M., Wang Z., Gallagher D., St-Onge M.P., Albu J., et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol 2004, 97:2333-2338.
29. Mitsiopoulos N., Baumgartner R.N., Heymsfield S.B., Lyons W., Gallagher D., Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998, 85:115-122.
30. Prado C.M., Lieffers J.R., McCargar L.J., Reiman T., Sawyer M.B., Martin L., et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008, 9:629-635.
31. Riggio O., Angeloni S., Ciuffa L., Nicolini G., Attili A.F., Albanese C., et al. Malnutrition is not related to alterations in energy balance in patients with stable liver cirrhosis. Clin Nutr 2003, 22:553-559.
32. Harper A.E., Miller R.H., Block K.P. Branched-chain amino acid metabolism. Annu Rev Nutr 1984, 4:409-454.
33. Manders R.J., Little J.P., Forbes S.C., Candow D.G. Insulinotropic and muscle protein synthetic effects of branched-chain amino acids: potential therapy for type 2 diabetes and sarcopenia. Nutrients 2012, 4:1664-1678.
34. O'Brien A., Williams R. Nutrition in end-stage liver disease: principles and practice. Gastroenterology 2008, 134:1729-1740.
35. Cheung K., Lee S.S., Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol 2012, 10:117-125.
36. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39:412-423.
37. Goodpaster B.H., Park S.W., Harris T.B., Kritchevsky S.B., Nevitt M., Schwartz A.V., et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006, 61:1059-1064.
38. Alvares-da-Silva M.R., Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition 2005, 21:113-117.
39. Rantanen T., Harris T., Leveille S.G., Visser M., Foley D., Masaki K., et al. Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci 2000, 55:M168-M173.